Strategic Merger Orchid Orthopedic Solutions merged with Tecomet in May 2026, signaling an expanded global footprint and integrated capabilities across design, development, and manufacturing. This presents cross-sell opportunities to Tecomet’s existing customer base and access to broader medical device programs.

End-to-End Outsourcing Orchid offers comprehensive services from concept through finished goods, including implant and instrument manufacturing, sterile and non-sterile packaging, and regulatory support. Sales opportunities exist to clients seeking a single partner for design, quality, regulatory, and manufacturing needs.

Orthopedic Focus With core strengths in joint reconstruction, spine, trauma, sports medicine, craniomaxillofacial, and orthobiologics, there is potential to target health systems and OEMs expanding orthopedic portfolios, including dental and minimally invasive solutions.

Global Capabilities A worldwide footprint and 1,500+ skilled employees enable support for multi-region programs, rapid scale, and localized regulatory and quality processes—advantageous for customers seeking global manufacturing with consistent standards.

Strategic Partnerships Recent collaborations such as with Rösler Oberflächentechnik for precise finishing, and joint ventures or AM-related work with Maxx Orthopedics, indicate openness to alliance-based growth and technology-enabled manufacturing, presenting partnership-led sales angles.